In our study, TERT promoter mutations were significantly more common in HCC related to HCV infection (5/6; 83.3%) compared to tumors of other etiologies; however, CTNNB1 mutations did not differ between HBV-related HCC and other etiologies-related HCC. This evidence concerns the gene TERT and hepatocellular carcinoma.